Chronic motor neuropathies: diagnosis, therapy, and pathogenesis

Area of Science:

• Neurology
• Immunology

Background:

• Pure motor neuropathies (PMN) present similarly to amyotrophic lateral sclerosis (ALS) but lack upper motor neuron signs.
• Distinguishing PMN is crucial as they are often immune-mediated and responsive to treatment, unlike ALS.

Purpose of the Study:

• To highlight the diagnostic features and treatment strategies for pure motor neuropathy syndromes.
• To differentiate PMN from ALS and emphasize their distinct, treatable nature.

Main Methods:

• Clinical assessment of neuropathy presentation (distal, asymmetrical, slow progression).
• Electrophysiological testing to identify demyelinative features (conduction block, prolonged latencies, F-wave abnormalities).
• Serum autoantibody analysis, particularly anti-GM1 antibodies, for diagnostic confirmation.

Main Results:

• Electrophysiological findings like motor conduction block and demyelinative signs aid diagnosis.
• Specific autoantibody patterns, especially high-titer anti-GM1, are frequently observed.
• Treatment with cyclophosphamide, plasma exchange, or immune globulin shows variable response times based on neuropathy type (demyelinative vs. axonal).

Conclusions:

• Pure motor neuropathies are distinct from ALS, characterized by immune-mediated processes.
• Prompt diagnosis through clinical, electrophysiological, and serological markers enables effective, targeted therapy.
• Treatment response varies, with quicker results in demyelinative cases and delayed responses in axonal forms.